However, the tyrosine kinase family receptors have been studied in Alzheimer’s disease, wherein the soluble ectodomain of AXL receptor tyrosine kinase, released following AXL activation, demonstrated predictive value for Alzheimer’s disease development [33]. This evidence concerns the gene NTRK1 and early-onset autosomal dominant Alzheimer disease.